| Serial Number | 79425256 |
| Word Mark | ADIPOPHARMA |
| Filing Date | Tuesday, April 1, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, March 27, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the wording "ADIPOPHARMA" in stylized font wherein the lettering "ADIPO" is in blue and "PHARMA" is in pink; to the left of the wording is a stylized cloud-like formation which appears from left to right in the colors white with grey shading, blue with dark blue shading, white with grey shading, pink with dark pink shading, blue with dark blue shading, and white with grey shading; partially enclosing the right side of the formation is the orange outline of an incomplete circle. |
| Indication of Colors claimed | The color(s) white, grey, pink, dark pink, blue, dark blue, and orange is/are claimed as a feature of the mark. |
| Goods and Services | Scientific and technological services, namely, research and design relating to drugs, pharmaceuticals, medicine; research and development services in the field of pharmacy and in particular medicines; research and development of new products for third parties; biological research; bacteriological research; chemical research; cosmetic science research; technical research in the field of new product development; scientific laboratory services; chemical analysis; material testing; technical project studies namely, conducting of feasibility studies in the field of new technologies; surveying being engineering services, engineering |
| Goods and Services | Pharmaceutical and veterinary preparations for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; medications for human medicine for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for medical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for pharmaceutical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; diagnostic preparations for medical use; cultures of microorganisms for medical use; stem cells for medical use; sanitary preparations for medical purposes; foodstuffs and dietetic food and beverages adapted for medical or veterinary use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 5, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 5, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AdipoPharma |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Thursday, June 5, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 6, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 28, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 10, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, September 11, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, October 28, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, October 28, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 15, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, March 25, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 25, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 25, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |